Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALNY

Alnylam

$87.49

-2.29 (-2.55%)

12:59
04/15/19
04/15
12:59
04/15/19
12:59
Recommendations
Alnylam analyst commentary at Piper Jaffray »

Lumasiran could give…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

ALNY

Alnylam

$89.78

1.68 (1.91%)

09:21
04/15/19
04/15
09:21
04/15/19
09:21
Recommendations
Alnylam analyst commentary at BMO Capital »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALNY

Alnylam

$89.78

1.68 (1.91%)

08:24
04/15/19
04/15
08:24
04/15/19
08:24
Recommendations
Alnylam analyst commentary at Nomura Instinet »

Positive givosiran data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALNY

Alnylam

$89.78

1.68 (1.91%)

07:14
04/15/19
04/15
07:14
04/15/19
07:14
Recommendations
Alnylam analyst commentary at Stifel »

Alnylam data affirm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALNY

Alnylam

$89.78

1.68 (1.91%)

07:08
04/15/19
04/15
07:08
04/15/19
07:08
Hot Stocks
Alnylam initiates ILLUMINATE-B Phase 3 pediatric study of lumasiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALNY

Alnylam

$89.78

1.68 (1.91%)

05:18
04/15/19
04/15
05:18
04/15/19
05:18
Recommendations
Alnylam analyst commentary at Piper Jaffray »

Piper continues to expect…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ABBV

AbbVie

$80.78

0.07 (0.09%)

, ICPT

Intercept

$95.04

-9.71 (-9.27%)

04:55
04/14/19
04/14
04:55
04/14/19
04:55
Conference/Events
European Association for the Study of the Liver to hold a meeting »

EASL International Liver…

ABBV

AbbVie

$80.78

0.07 (0.09%)

ICPT

Intercept

$95.04

-9.71 (-9.27%)

VRTX

Vertex

$182.69

-2.4 (-1.30%)

GILD

Gilead

$65.27

-1.04 (-1.57%)

AGN

Allergan

$144.94

-0.08 (-0.06%)

GNFT

Genfit

$24.84

-0.02 (-0.08%)

ALNY

Alnylam

$89.78

1.68 (1.91%)

APEN

Apollo Endosurgery

$3.43

-0.025 (-0.72%)

BMY

Bristol-Myers

$45.58

-0.52 (-1.13%)

CBAY

CymaBay

$12.50

-0.6 (-4.58%)

CTSO

CytoSorbents

$7.16

-0.28 (-3.76%)

EIGR

Eiger BioPharmaceuticals

$14.25

-0.04 (-0.28%)

ENTA

Enanta

$92.32

0.42 (0.46%)

NDRA

ENDRA Life Sciences

$1.51

(0.00%)

IPSEY

Ipsen

$0.00

(0.00%)

MYRG

MYR Group

$36.36

-0.14 (-0.38%)

NVS

Novartis

$80.26

-1.615 (-1.97%)

NVO

Novo Nordisk

$50.21

-0.74 (-1.45%)

OSUR

OraSure

$10.12

-0.12 (-1.17%)

SIEGY

Siemens

$0.00

(0.00%)

JNJ

Johnson & Johnson

$136.00

0.72 (0.53%)

SBPH

Spring Bank Pharmaceuticals

$9.54

-0.29 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 17

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 28

    May

  • 29

    May

  • 05

    Jun

  • 06

    Aug

  • 13

    Nov

ALNY

Alnylam

$89.78

1.68 (1.91%)

07:55
04/13/19
04/13
07:55
04/13/19
07:55
Conference/Events
Alnylam to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Apr

  • 25

    Apr

ALNY

Alnylam

$89.78

1.68 (1.91%)

04:55
04/13/19
04/13
04:55
04/13/19
04:55
Conference/Events
Alnylam to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Apr

  • 25

    Apr

ABBV

AbbVie

$80.78

0.07 (0.09%)

, ICPT

Intercept

$95.04

-9.71 (-9.27%)

04:55
04/13/19
04/13
04:55
04/13/19
04:55
Conference/Events
European Association for the Study of the Liver to hold a meeting »

EASL International Liver…

ABBV

AbbVie

$80.78

0.07 (0.09%)

ICPT

Intercept

$95.04

-9.71 (-9.27%)

VRTX

Vertex

$182.69

-2.4 (-1.30%)

GILD

Gilead

$65.27

-1.04 (-1.57%)

AGN

Allergan

$144.94

-0.08 (-0.06%)

GNFT

Genfit

$24.84

-0.02 (-0.08%)

ALNY

Alnylam

$89.78

1.68 (1.91%)

APEN

Apollo Endosurgery

$3.43

-0.025 (-0.72%)

BMY

Bristol-Myers

$45.58

-0.52 (-1.13%)

CBAY

CymaBay

$12.50

-0.6 (-4.58%)

CTSO

CytoSorbents

$7.16

-0.28 (-3.76%)

EIGR

Eiger BioPharmaceuticals

$14.25

-0.04 (-0.28%)

ENTA

Enanta

$92.32

0.42 (0.46%)

NDRA

ENDRA Life Sciences

$1.51

(0.00%)

IPSEY

Ipsen

$0.00

(0.00%)

MYRG

MYR Group

$36.36

-0.14 (-0.38%)

NVS

Novartis

$80.26

-1.615 (-1.97%)

NVO

Novo Nordisk

$50.21

-0.74 (-1.45%)

OSUR

OraSure

$10.12

-0.12 (-1.17%)

SIEGY

Siemens

$0.00

(0.00%)

JNJ

Johnson & Johnson

$136.00

0.72 (0.53%)

SBPH

Spring Bank Pharmaceuticals

$9.54

-0.29 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Apr

  • 16

    Apr

  • 17

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 28

    May

  • 29

    May

  • 05

    Jun

  • 06

    Aug

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.